Clasemagistral DR. PAIPA
Clasemagistral DR. PAIPA
Clasemagistral DR. PAIPA
Segmento Anterior
Segmento Anterior
Fondo de Ojo
ERRORES DE LA REFRACCIN
Miopa
Miopa
Miopa
Astigmatismo
Astigmatismo
Ciruga de Refraccin
Cartilla de Snellen
Cartilla de Snellen
Anillos de Landolt
Agujero Estenopico
Tablas de Ishihara
Instrumentos de Exploracin
Exploracin
RETINOPATIA DIABETICA
Retinopata Diabtica
Retinopata Diabtica
Retinopata Diabtica
Retinopata Diabtica
Retinopata Diabtica
Retinopata Diabtica
Retinopata Diabtica
Retinopata Diabtica
Retinopata Diabtica
Retinopata Diabtica
Retinopata Diabtica
Retinopata Diabtica
Glaucoma
Fondo de Ojo
Glaucoma
Glaucoma
Tonmetro
Tonmetro
Glaucoma
Glaucoma
Glaucoma
Glaucoma
Glaucoma
Glaucoma
Glaucoma
Campimetra de Humphrey
Campimetra de Humphrey
Msculos Extraoculares
Msculos Extraoculares
Msculos Extraoculares
Ducciones y Versiones
Ducciones y Versiones
Estrabismo
Estrabismo
Estrabismo
Estrabismo
Estrabismo
Estrabismo
Estrabismo
Estrabismo
Reflejo Rojo
Reflejo Rojo
Reflejo rojo
Reflejo Rojo
Retinoblastoma
Movimientos Oculares
Ducciones y Versiones
Estrabismo
Estrabismo
Estrabismo
Estrabismo
Estrabismo
Estrabismo
Estrabismo
Estrabismo
Estrabismo
Estrabismo
Bibliografa
1. UKPDS Group. UK: Prospective Diabetes Study 33. Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-53. 2. UKPDS Group. UK: UKPDS 38. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 1998;317:703-13. 3. Modan, M, Halkin H, Almog S, Lusky A, Eshkol, A., Shefi M, Shitret A, et al. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerabce. J Clin Invest 1985;75:809-17. 4. Reaven GM. Syndrome X: 6 years later. J Inter Med 1994:236 (Suppl 736):13-22. 5. The Metabolic Cardiovascular Syndrome: Syndrome X, Reaven Syndrome, insulin resistance syndrome, atherothrombogenic syndrome. J Cardiovasc Pharmacol 1992:20(Suppl 8):5-10. 6. Scheen AJ. Le syndrome plurimetabolique associe a linsulinoresistance ou Syndrome S: actualization aprs 10 ans. Diabetologie et facteurs de risque 977;3:254-58. 7. De Fronzo RA, Ferraran E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dislipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
Bibliografa
8. Sjoholm A. Time for more active lipid-lowering treatment of patients with diabetes. Negative effect of hyperlipidemia on b-cells is a neglected field. Lakartidningen 1998;95(50):5750-52. 9. UKDS Group. UK. Prospective Diabetes Study 6. Complications in Newly Diagnosis Type 2 Diabetic and their Association with different clinical and Biochemical Risk Factors. Diabetes Res 1990;13(1 1-11. 10 . Lapertosa S, Dionisi D, Sosa M. et al. Complicaciones en el diabtico tipo 2 recin diagnosticado. Oma Congreso ALAD. Cartagena de Indias, Colombia. Rev Assoc Latinoam Diabetes 1998;6(2):c64. 11. Damiano, M, Rebollo S, Castro P. Diabetes Tipo 2 complicaciones crnicas en el momento del diagnstico. 10mo Congreso de la ALAD. Cartagena de Indias. Colombia. Rev Asoc Latinoam Diabetes 1998;6(2):c-86. 12. Smith U, Takins MR. Prevention of dyslipidemia. The foremost challenge in the management of diabetes. Lakartidningen 1999:96(4):334-36. 13. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years follow-up from the Framingham study. JAMA 1987;257:2176-80. 14. Sociedade Brasileira de Cardiologia. 11 Consenso Brasileiro sobre Dislipidemias. Arq Brasil Cardiol 1996;67:1-16.
Bibliografa
15.
16. 17.
18. 19.
20.
21. 22. 23.
Ostermann H, Van de Loo J. Factors of the hemostatic system in diabetic patients. Haemostasis 1986;16:386-416. Skovborg F, Nielsen AV, Schilchtkrull J, Ditzel J. Lancet 1966 1:129-131. Hoare EM, Barnes AJ, Dormandy JA.: Abnormal blood viscosity in diabetes mellitus and retinopaty. Biorheology 1976;13:21-5. Grindle CFJ, Busjard NA, Neuman DL. Hyperviscosity in diabetes retinopathy. A scientific approach to therapy. Transophthalm Soc UK 1976;96:216. Salama Benarroch I, Rubinstein de Salama A. Blood viscosity in diabetic patients. Bol Soc Portug Hemorr Microcirc 2000;14(4). Salama Benarroch I, Rubinstein de Salama A, Bregni C. Correction of blood hyperviscosity in diabetes with microangiopathy by haematocrit reduction. Bol Soc Portug Hemorag Microcirc 2000;14(4). Lazzri A, Sutton M, Woods A, Salama Benarroch I, Rubeinstein de Salama A, Gaudero G. et al. Estudio de la funcin plaquetaria en el diabtico con lesiones vasculares tardas. An Acad Nac Med 1981;592. Albrink MJ, Lavietes PH, Mann EB.: Vascular disease and serum lipids in diabetes mellitus: observations of 30 years (1931-191). Ann Intern Med 1963;58:305. Report of the Expert Committee on Diagnosis and Clasification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.